Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Coso

Showing results (31-40 of 42) with videos related to

Pageof 5
Sort By:
Bone Marrow Transplantation|December 11, 2012
Disease status is a more reliable predictive factor than histology in lymphoma patients after reduced-intensity conditioning regimen and allo-SCTL Castagna, R Boubdallah, S Furst, et al.
Bone Marrow Transplantation|July 8, 2014
Reduced-intensity conditioning regimen with in vivo T-cell depletion for patients with haematological malignancies: results using unrelated and sibling donorsL Castagna, R Crocchiolo, S Furst, et al.
Bone Marrow Transplantation|June 11, 2013
Efficacy and safety of micafungin for prophylaxis of invasive fungal infections in patients undergoing haplo-identical hematopoietic SCTJ El-Cheikh, G Venton, R Crocchiolo, et al.
Journal of Viral Hepatitis|December 17, 2009
Clinical and virological factors associated with hepatitis B virus reactivation in HBsAg-negative and anti-HBc antibodies-positive patients undergoing chemotherapy and/or autologous stem cell transplantation for cancerP Borentain, P Colson, D Coso, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|April 24, 2013
Risk factors of Ganciclovir-related neutropenia after allogeneic stem cell transplantation: a retrospective monocentre study on 547 patientsG Venton, R Crocchiolo, S Fürst, et al.
Bone Marrow Transplantation|May 11, 2004
Graft-versus-myeloma effect following antithymocyte globulin-based reduced intensity conditioning allogeneic stem cell transplantationM Mohty, J M Boiron, G Damaj, et al.
Bone Marrow Transplantation|September 16, 2014
Nonmyeloablative conditioning, unmanipulated haploidentical SCT and post-infusion CY for advanced lymphomasL Castagna, S Bramanti, S Furst, et al.
Bone Marrow Transplantation|June 14, 2006
A phase II trial of rituximab as adjuvant to intensive sequential chemotherapy in patients under 60 years with untreated poor-prognosis diffuse large B-cell lymphomaD Coso, C Sebban, O Boulat, et al.
Leukemia|August 22, 2003
Infectious complications following allogeneic HLA-identical sibling transplantation with antithymocyte globulin-based reduced intensity preparative regimenM Mohty, W Jacot, C Faucher, et al.
Bone Marrow Transplantation|October 18, 2016
Outcomes of Hodgkin lymphoma patients who relapse after allogeneic stem cell transplantationL Castagna, B Sarina, R Crocchiolo, et al.
Pageof 5

Showing results (31-40 of 42) with videos related to

Sort By:
Pageof 5
Bone Marrow Transplantation|December 11, 2012
Disease status is a more reliable predictive factor than histology in lymphoma patients after reduced-intensity conditioning regimen and allo-SCTL Castagna, R Boubdallah, S Furst, et al.
Bone Marrow Transplantation|July 8, 2014
Reduced-intensity conditioning regimen with in vivo T-cell depletion for patients with haematological malignancies: results using unrelated and sibling donorsL Castagna, R Crocchiolo, S Furst, et al.
Bone Marrow Transplantation|June 11, 2013
Efficacy and safety of micafungin for prophylaxis of invasive fungal infections in patients undergoing haplo-identical hematopoietic SCTJ El-Cheikh, G Venton, R Crocchiolo, et al.
Journal of Viral Hepatitis|December 17, 2009
Clinical and virological factors associated with hepatitis B virus reactivation in HBsAg-negative and anti-HBc antibodies-positive patients undergoing chemotherapy and/or autologous stem cell transplantation for cancerP Borentain, P Colson, D Coso, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|April 24, 2013
Risk factors of Ganciclovir-related neutropenia after allogeneic stem cell transplantation: a retrospective monocentre study on 547 patientsG Venton, R Crocchiolo, S Fürst, et al.
Bone Marrow Transplantation|May 11, 2004
Graft-versus-myeloma effect following antithymocyte globulin-based reduced intensity conditioning allogeneic stem cell transplantationM Mohty, J M Boiron, G Damaj, et al.
Bone Marrow Transplantation|September 16, 2014
Nonmyeloablative conditioning, unmanipulated haploidentical SCT and post-infusion CY for advanced lymphomasL Castagna, S Bramanti, S Furst, et al.
Bone Marrow Transplantation|June 14, 2006
A phase II trial of rituximab as adjuvant to intensive sequential chemotherapy in patients under 60 years with untreated poor-prognosis diffuse large B-cell lymphomaD Coso, C Sebban, O Boulat, et al.
Leukemia|August 22, 2003
Infectious complications following allogeneic HLA-identical sibling transplantation with antithymocyte globulin-based reduced intensity preparative regimenM Mohty, W Jacot, C Faucher, et al.
Bone Marrow Transplantation|October 18, 2016
Outcomes of Hodgkin lymphoma patients who relapse after allogeneic stem cell transplantationL Castagna, B Sarina, R Crocchiolo, et al.
Pageof 5